NEW YORK (GenomeWeb News) – Waters and the Irish National Institute for Bioprocessing Research and Training said today that they have established a multi-level partnership for the study of biotherapeutic design.
Under the partnership, the two parties have established the Complete Product and Processing Characterization Facility, a center for training scientists in "fit-for-purpose" biopharmaceutical analysis including protein and peptide characterization, as well as educating them on existing and pending US and European drug regulations.
The partnership also establishes NIBRT as a Waters Center of Innovation in the area of glycobiology. NIBRT principal investigator Pauline Rudd will work with Waters' mass spectrometry systems to improve techniques for glycan analysis, a key aspect of biotherapeutic design and processing.
"This partnership will enable NIBRT, with the help of Waters, to provide advanced solutions for the pharmaceutical industry, including protein characterization, N- and O- glycan analysis," NIBRT Interim Director Ian Marison said in a statement.
Financial and other terms of the partnership were not disclosed.
The deal follows on a 2010 agreement between Waters and Rudd's group at NIBRT to develop a database for glycan analysis by ultra performance liquid chromatography.
As reported by GenomeWeb Daily News sister publication ProteoMonitor, that project called for Rudd and NBIRT to build a repository of chromatographic retention times for sets of glycan structures that biopharma companies could use for confirming the structures of glycosylated proteins.
NIBRT maintains and licenses the database, co-marketing it with Waters.